ICU Medical, Inc. (ICUI) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es SMITHS GROUP PLC con 1,670,000 acciones. Otros tenedores destacados incluyen Smiths Group International Holdings Ltd y LOPEZ GEORGE A.
En los últimos 12 meses, los internos han realizado 44 transacciones en ICUI acciones — 2 compras (valoradas en $342.55K) y 14 ventas (valoradas en $7.35M). Las ventas internas han superado las compras durante este período.
ICUI Participación de Insiders
Principal Titular
SMITHS GROUP PLC
1,670,000 acciones
Compras (12 meses)
2
$342.55K valor
Ventas (12 meses)
14
$7.35M valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Smiths Group Plc |
Other: Former 10% Owner |
1,670,000 |
2024-03-01 |
|
| 2 |
Smiths Group International Holdings Ltd |
Other: Former 10% Owner |
1,670,000 |
2024-03-01 |
|
| 3 |
Lopez George A |
Director |
885,321 |
2024-03-14 |
|
| 4 |
Swinney Robert S |
Director |
20,816 |
2021-09-15 |
|
| 5 |
Jain Vivek |
Chairman and CEO |
10,566 |
2026-03-09 |
|
| 6 |
Greenberg David C. |
Director |
7,362 |
2025-08-27 |
|
| 7 |
Voigtlander Christian B. |
Chief Operating Officer |
7,044 |
2026-03-09 |
|
| 8 |
Bonnell Brian Michael |
Chief Financial Officer |
7,044 |
2026-03-09 |
|
| 9 |
Sanzone Virginia Ruth |
VP, General Counsel |
6,507 |
2026-03-09 |
|
| 10 |
Abbey Donald |
Director |
4,046 |
2026-03-26 |
|
| 11 |
Mcgrody Kevin J |
Chief Accounting Officer |
4,027 |
2022-03-08 |
|
| 12 |
Finney Elisha W |
Director |
3,252 |
2025-05-20 |
|
| 13 |
Woolson Daniel |
VP, GM-infusion Capital |
3,170 |
2026-03-09 |
|
| 14 |
Sousa Ben |
Chief Information Officer |
1,106 |
2026-03-09 |
|
| 15 |
Lamb Scott E |
Chief Financial Officer, |
1,005 |
2020-02-14 |
|
| 16 |
Burcar Alison D |
Vice President and Gen'l Mgr. |
512 |
2019-03-28 |
|
| 17 |
Kennedy Kolleen T |
Director |
485 |
2022-05-18 |
|
| 18 |
Hernandez Laurie |
Director |
485 |
2022-05-18 |
|
| 19 |
Hoffmeister David F |
Director |
485 |
2022-05-18 |
|
| 20 |
Mccall Thomas D |
Vice President and Gen'l Mgr. |
351 |
2019-03-28 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-03-25 |
Abbey Donald |
Director |
Otro (Venta) |
704 |
- |
- |
| 2026-03-15 |
Sousa Ben |
Chief Information Officer |
Ejercicio de Opciones (Venta) |
1,300 |
- |
- |
| 2026-03-15 |
Bonnell Brian Michael |
Chief Financial Officer |
Ejercicio de Opciones (Venta) |
11,400 |
- |
- |
| 2026-03-15 |
Voigtlander Christian B. |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
11,400 |
- |
- |
| 2026-03-15 |
Woolson Daniel |
VP, GM-infusion Capital |
Ejercicio de Opciones (Venta) |
2,924 |
- |
- |
| 2026-03-15 |
Sanzone Virginia Ruth |
VP, General Counsel |
Ejercicio de Opciones (Venta) |
1,624 |
- |
- |
| 2026-03-15 |
Jain Vivek |
Chairman and CEO |
Ejercicio de Opciones (Venta) |
17,100 |
- |
- |
| 2026-03-08 |
Sousa Ben |
Chief Information Officer |
Ejercicio de Opciones (Venta) |
7,177 |
- |
- |
| 2026-03-07 |
Sousa Ben |
Chief Information Officer |
Retención Fiscal de RSU |
782 |
$132.00 |
$103.22K |
| 2026-03-08 |
Bonnell Brian Michael |
Chief Financial Officer |
Ejercicio de Opciones (Venta) |
71,757 |
- |
- |
| 2026-03-07 |
Bonnell Brian Michael |
Chief Financial Officer |
Ejercicio de Opciones (Venta) |
3,522 |
- |
- |
| 2026-03-08 |
Voigtlander Christian B. |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
71,757 |
- |
- |
| 2026-03-07 |
Voigtlander Christian B. |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
3,522 |
- |
- |
| 2026-03-08 |
Woolson Daniel |
VP, GM-infusion Capital |
Ejercicio de Opciones (Venta) |
16,147 |
- |
- |
| 2026-03-07 |
Woolson Daniel |
VP, GM-infusion Capital |
Ejercicio de Opciones (Venta) |
1,585 |
- |
- |
| 2026-03-08 |
Sanzone Virginia Ruth |
VP, General Counsel |
Ejercicio de Opciones (Venta) |
23,917 |
- |
- |
| 2026-03-07 |
Sanzone Virginia Ruth |
VP, General Counsel |
Retención Fiscal de RSU |
1,297 |
$132.00 |
$171.2K |
| 2026-03-08 |
Jain Vivek |
Chairman and CEO |
Ejercicio de Opciones (Venta) |
107,635 |
- |
- |
| 2026-03-07 |
Jain Vivek |
Chairman and CEO |
Ejercicio de Opciones (Venta) |
5,282 |
- |
- |
| 2025-11-25 |
Woolson Daniel |
VP, GM-infusion Capital |
Venta Informativa |
2,897 |
$152.35 |
$441.36K |
| 2025-11-11 |
Sanzone Virginia Ruth |
VP, General Counsel |
Venta Informativa |
930 |
$142.35 |
$132.38K |
| 2025-11-11 |
Finney Elisha W |
Director |
Ejercicio de Opciones (Venta) |
1,285 |
$103.76 |
$133.33K |
| 2025-09-12 |
Jain Vivek |
Chairman and CEO |
Donación (Otorgada) |
63,641 |
- |
- |
| 2025-08-27 |
Greenberg David C. |
Director |
Compra Informativa |
602 |
$126.14 |
$75.94K |
| 2025-08-14 |
Jain Vivek |
Chairman and CEO |
Compra Informativa |
2,378 |
$112.12 |
$266.61K |
